• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Risk-benefit ratio assessment for stroke prevention in intermediate risk atrial fibrillation patients: will TEE-based aspirin treatment fill the gap?

作者信息

Smit M D, Van Gelder I C

机构信息

Department of Cardiology, Thoraxcenter, University Medical Center Groningen, University of Groningen, P.O. Box 30.001, 9700 RB, Groningen, the Netherlands.

出版信息

Neth Heart J. 2011 May;19(5):212-3. doi: 10.1007/s12471-011-0119-z.

DOI:10.1007/s12471-011-0119-z
PMID:21487742
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3087023/
Abstract
摘要

相似文献

1
Risk-benefit ratio assessment for stroke prevention in intermediate risk atrial fibrillation patients: will TEE-based aspirin treatment fill the gap?中度风险心房颤动患者预防卒中的风险效益比评估：基于经食管超声心动图的阿司匹林治疗能否填补空白？
Neth Heart J. 2011 May;19(5):212-3. doi: 10.1007/s12471-011-0119-z.
2
Transesophageal echocardiographic correlates of clinical risk of thromboembolism in nonvalvular atrial fibrillation. Stroke Prevention in Atrial Fibrillation III Investigators.非瓣膜性心房颤动血栓栓塞临床风险的经食管超声心动图相关性。心房颤动卒中预防III研究组。
J Am Coll Cardiol. 1998 Jun;31(7):1622-6. doi: 10.1016/s0735-1097(98)00146-6.
3
Transesophageal echocardiographic correlates of thromboembolism in high-risk patients with nonvalvular atrial fibrillation. The Stroke Prevention in Atrial Fibrillation Investigators Committee on Echocardiography.非瓣膜性心房颤动高危患者血栓栓塞的经食管超声心动图相关性。心房颤动预防卒中研究超声心动图委员会。
Ann Intern Med. 1998 Apr 15;128(8):639-47. doi: 10.7326/0003-4819-128-8-199804150-00005.
4
Antithrombotic therapy in atrial fibrillation: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).心房颤动的抗栓治疗：美国胸科医师学会循证临床实践指南（第8版）
Chest. 2008 Jun;133(6 Suppl):546S-592S. doi: 10.1378/chest.08-0678.
5
Warfarin versus aspirin for prevention of thromboembolism in atrial fibrillation: Stroke Prevention in Atrial Fibrillation II Study.华法林与阿司匹林预防心房颤动血栓栓塞的比较：心房颤动卒中预防II研究
Lancet. 1994 Mar 19;343(8899):687-91.
6
Pathophysiologic correlates of thromboembolism in nonvalvular atrial fibrillation: I. Reduced flow velocity in the left atrial appendage (The Stroke Prevention in Atrial Fibrillation [SPAF-III] study).非瓣膜性心房颤动血栓栓塞的病理生理相关性：I. 左心耳血流速度降低（心房颤动卒中预防 [SPAF-III] 研究）
J Am Soc Echocardiogr. 1999 Dec;12(12):1080-7. doi: 10.1016/s0894-7317(99)70105-7.
7
Aspirin versus vitamin K antagonist treatment guided by transoesophageal echocardiography in patients with atrial fibrillation: a pilot study.经食管超声心动图指导的房颤患者阿司匹林与维生素 K 拮抗剂治疗：一项初步研究。
Heart. 2014 Apr;100(7):563-8. doi: 10.1136/heartjnl-2013-305017. Epub 2014 Jan 31.
8
Lessons from the Stroke Prevention in Atrial Fibrillation trials.心房颤动卒中预防试验的经验教训。
Ann Intern Med. 2003 May 20;138(10):831-8. doi: 10.7326/0003-4819-138-10-200305200-00011.
9
Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation. Analysis of pooled data from five randomized controlled trials.心房颤动患者中风的危险因素及抗血栓治疗的疗效。五项随机对照试验汇总数据的分析。
Arch Intern Med. 1994 Jul 11;154(13):1449-57.
10
Feasibility of TEE-guided stroke risk assessment in atrial fibrillation-background, aims, design and baseline data of the TIARA pilot study.经食管超声心动图引导的房颤卒中风险评估的可行性：TIARA 研究的背景、目的、设计和基线数据。
Neth Heart J. 2011 May;19(5):214-22. doi: 10.1007/s12471-011-0095-3.

引用本文的文献

1
Neurocardiology: close interaction between heart and brain.神经心脏病学：心脏与大脑之间的密切相互作用。
Neth Heart J. 2013 Feb;21(2):51-2. doi: 10.1007/s12471-012-0369-4.

本文引用的文献

1
Feasibility of TEE-guided stroke risk assessment in atrial fibrillation-background, aims, design and baseline data of the TIARA pilot study.经食管超声心动图引导的房颤卒中风险评估的可行性：TIARA 研究的背景、目的、设计和基线数据。
Neth Heart J. 2011 May;19(5):214-22. doi: 10.1007/s12471-011-0095-3.
2
Apixaban in patients with atrial fibrillation.阿哌沙班用于房颤患者。
N Engl J Med. 2011 Mar 3;364(9):806-17. doi: 10.1056/NEJMoa1007432. Epub 2011 Feb 10.
3
Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC).心房颤动管理指南：欧洲心脏病学会（ESC）心房颤动管理特别工作组
Europace. 2010 Oct;12(10):1360-420. doi: 10.1093/europace/euq350.
4
Lenient versus strict rate control in patients with atrial fibrillation.宽松与严格的心率控制在心房颤动患者中的比较。
N Engl J Med. 2010 Apr 15;362(15):1363-73. doi: 10.1056/NEJMoa1001337. Epub 2010 Mar 15.
5
Dabigatran versus warfarin in patients with atrial fibrillation.达比加群与华法林用于房颤患者的比较。
N Engl J Med. 2009 Sep 17;361(12):1139-51. doi: 10.1056/NEJMoa0905561. Epub 2009 Aug 30.
6
Stroke and thromboembolism in atrial fibrillation: a systematic review of stroke risk factors, risk stratification schema and cost effectiveness data.心房颤动中的中风与血栓栓塞：中风危险因素、风险分层方案及成本效益数据的系统评价
Thromb Haemost. 2008 Feb;99(2):295-304. doi: 10.1160/TH07-08-0508.
7
ACC/AHA/ESC 2006 Guidelines for the Management of Patients with Atrial Fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society.美国心脏病学会/美国心脏协会/欧洲心脏病学会2006年心房颤动患者管理指南：美国心脏病学会/美国心脏协会实践指南工作组和欧洲心脏病学会实践指南委员会（修订2001年心房颤动患者管理指南写作委员会）报告：与欧洲心律协会和心律协会合作制定。
Circulation. 2006 Aug 15;114(7):e257-354. doi: 10.1161/CIRCULATIONAHA.106.177292.
8
Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomised controlled trial.氯吡格雷联合阿司匹林与口服抗凝药用于房颤患者预防血管事件的氯吡格雷与厄贝沙坦试验（ACTIVE W）：一项随机对照试验
Lancet. 2006 Jun 10;367(9526):1903-12. doi: 10.1016/S0140-6736(06)68845-4.
9
Transesophageal echocardiographic correlates of clinical risk of thromboembolism in nonvalvular atrial fibrillation. Stroke Prevention in Atrial Fibrillation III Investigators.非瓣膜性心房颤动血栓栓塞临床风险的经食管超声心动图相关性。心房颤动卒中预防III研究组。
J Am Coll Cardiol. 1998 Jun;31(7):1622-6. doi: 10.1016/s0735-1097(98)00146-6.